Amediplase

Drug Profile

Amediplase

Alternative Names: CGP 42935; K2tu-PA; MEN 9036

Latest Information Update: 03 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Menarini
  • Class Blood coagulation factors; Plasminogen activator enzymes; Serine endopeptidases; Thrombolytics
  • Mechanism of Action Plasminogen activators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Myocardial infarction

Most Recent Events

  • 08 Jun 2005 This compound is still in active development
  • 08 May 2001 A clinical study has been added to the adverse events, pharmacokinetics, Ischaemic Heart Disease and Thromboses pharmacodynamics sections
  • 21 Oct 1998 Phase-II clinical trials for Myocardial infarction in Europe (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top